Targeting histone modifiers in bladder cancer therapy — preclinical and clinical evidence
Nature Reviews Urology, Published online: 19 February 2024; doi:10.1038/s41585-024-00857-zIn this Perspective, the authors discuss the idea of targeting histone modifications in bladder cancer, providing a comprehensive overview of findings from preclinical and translational studies. Clinical trials in which the efficacy of molecules targeting histone modifiers was assessed in bladder cancer are also discussed.
Source: Nature Reviews Urology - Category: Urology & Nephrology Authors: Shiyu Zhang Tianhai Lin Xingyu Xiong Chong Chen Ping Tan Qiang Wei Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Cancer Therapy | Clinical Trials | Study | Urology & Nephrology